5-161878065-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001127644.2(GABRA1):​c.559+2423C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.513 in 152,006 control chromosomes in the GnomAD database, including 20,833 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.51 ( 20833 hom., cov: 33)

Consequence

GABRA1
NM_001127644.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.276

Publications

2 publications found
Variant links:
Genes affected
GABRA1 (HGNC:4075): (gamma-aminobutyric acid type A receptor subunit alpha1) This gene encodes a gamma-aminobutyric acid (GABA) receptor. GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. GABA-A receptors are pentameric, consisting of proteins from several subunit classes: alpha, beta, gamma, delta and rho. Mutations in this gene cause juvenile myoclonic epilepsy and childhood absence epilepsy type 4. Multiple transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jul 2008]
GABRA1 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 19
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, idiopathic generalized, susceptibility to, 13
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Dravet syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • juvenile myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.98).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.633 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001127644.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
NM_001127644.2
MANE Select
c.559+2423C>T
intron
N/ANP_001121116.1P14867
GABRA1
NM_000806.5
c.559+2423C>T
intron
N/ANP_000797.2A8K177
GABRA1
NM_001127643.2
c.559+2423C>T
intron
N/ANP_001121115.1P14867

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA1
ENST00000393943.10
TSL:1 MANE Select
c.559+2423C>T
intron
N/AENSP00000377517.4P14867
GABRA1
ENST00000023897.10
TSL:1
c.559+2423C>T
intron
N/AENSP00000023897.6P14867
GABRA1
ENST00000428797.7
TSL:1
c.559+2423C>T
intron
N/AENSP00000393097.2P14867

Frequencies

GnomAD3 genomes
AF:
0.513
AC:
77972
AN:
151888
Hom.:
20800
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.628
Gnomad AMI
AF:
0.493
Gnomad AMR
AF:
0.426
Gnomad ASJ
AF:
0.488
Gnomad EAS
AF:
0.651
Gnomad SAS
AF:
0.616
Gnomad FIN
AF:
0.518
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.446
Gnomad OTH
AF:
0.515
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.513
AC:
78040
AN:
152006
Hom.:
20833
Cov.:
33
AF XY:
0.517
AC XY:
38380
AN XY:
74288
show subpopulations
African (AFR)
AF:
0.628
AC:
26052
AN:
41454
American (AMR)
AF:
0.426
AC:
6504
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.488
AC:
1690
AN:
3466
East Asian (EAS)
AF:
0.651
AC:
3369
AN:
5174
South Asian (SAS)
AF:
0.614
AC:
2964
AN:
4824
European-Finnish (FIN)
AF:
0.518
AC:
5461
AN:
10538
Middle Eastern (MID)
AF:
0.551
AC:
162
AN:
294
European-Non Finnish (NFE)
AF:
0.446
AC:
30291
AN:
67976
Other (OTH)
AF:
0.520
AC:
1097
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1943
3887
5830
7774
9717
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
694
1388
2082
2776
3470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.464
Hom.:
65969
Bravo
AF:
0.514
Asia WGS
AF:
0.657
AC:
2283
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.98
CADD
Benign
5.1
DANN
Benign
0.54
PhyloP100
0.28
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6878494; hg19: chr5-161305071; API